Anbio Biotechnology, a leader in in-vitro diagnostic technologies, announced its participation in three international exhibitions in May 2025: EuroMedLab in Brussels, AVA Conference in Sydney, and ...

BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international ...

Anbio Biotechnology reported strong 2025 results with sales of $8.65M. The company is diversifying away from COVID products.

Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 8, 2025 ...

NNNN continues pivoting toward better profitability metrics. They’ve prioritized high-margin orders over sales volume. In practice, this has improved near-term operating metrics, but their topline has ...

View Anbio Biotechnology Class A NNNN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Explore Anbio Biotechnology analyst ratings and price targets (NASDAQ:NNNN) on Benzinga. Stay updated on expert opinions and forecasts for NNNN stock. There is no next analyst rating for Anbio ...

Anbio Biotechnology Class A ( (NNNN)) has issued an announcement. Anbio Biotechnology has convened a meeting of Class A shareholders and an extraordinary general meeting for May 15, 2026, in Frankfurt ...

Anbio Biotechnology (NASDAQ:NNNN) is one of the 13 Best German Stocks to Invest in Now. The company is engaged in the development of medical technology and the provision of in vitro diagnostics ...

BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international ...

Anbio Biotechnology Annual stock financials by MarketWatch. View the latest NNNN financial statements, income statements and financial ratios.